| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenues | $3.31B+6.2% | $3.11B+13.5% | $2.74B+8.0% | $2.54B+14.1% | $2.23B+19.6% | $1.86B+1.6% | $1.83B+3.4% | $1.77B |
| Salaries and benefits | $971.0M+7.0% | $907.5M+14.3% | $793.8M+6.4% | $746.4M+15.8% | $644.3M+17.1% | $550.3M+0.1% | $550.0M+2.9% | $534.7M |
| Supplies | $878.9M+8.1% | $812.9M+9.1% | $745.0M+5.0% | $709.7M+11.5% | $636.4M+18.2% | $538.4M+6.0% | $507.9M+3.6% | $490.3M |
| Professional and medical fees | $404.5M+13.3% | $357.1M+20.3% | $296.8M+10.3% | $269.2M+17.0% | $230.0M+20.2% | $191.4M+23.6% | $154.8M+6.4% | $145.5M |
| Lease expense | $87.9M-1.8% | $89.5M+5.4% | $84.9M+3.0% | $82.4M-9.1% | $90.6M+3.7% | $87.4M+2.1% | $85.6M-1.3% | $86.7M |
| Other operating expenses | $201.4M-0.1% | $201.7M+15.1% | $175.3M+11.9% | $156.7M+18.4% | $132.4M+17.4% | $112.8M+3.2% | $109.3M+4.9% | $104.2M |
| Cost of revenues | $2.54B+7.4% | $2.37B+13.0% | $2.10B+6.7% | $1.96B+13.3% | $1.73B+17.1% | $1.48B+5.2% | $1.41B+3.4% | $1.36B |
| General and administrative expenses | $118.2M-14.8% | $138.7M+14.7% | $120.9M+18.3% | $102.2M-1.7% | $104.0M+7.1% | $97.1M+9.6% | $88.6M-5.3% | $93.6M |
| Depreciation and amortization | $176.0M+15.3% | $152.6M+29.2% | $118.1M+2.9% | $114.8M+16.2% | $98.8M+4.2% | $94.8M+23.9% | $76.5M+13.5% | $67.4M |
| Transaction and integration costs | $73.9M-26.2% | $100.1M+62.2% | $61.7M+29.9% | $47.5M+19.3% | $39.8M+71.6% | $23.2M+22.1% | $19.0M-40.1% | $31.7M |
| Net loss on disposals, consolidations and deconsolidations | $30.4M-25.1% | $40.6M+181.9% | $14.4M+29.7% | $11.1M+404.5% | $2.2M-61.4% | $5.7M+229.5% | -$4.4M-113.8% | $31.8M |
| Equity in earnings of unconsolidated affiliates | -$22.9M-17.4% | -$19.5M-37.3% | -$14.2M-13.6% | -$12.5M-10.6% | -$11.3M-4.6% | -$10.8M-5.9% | -$10.2M-14.6% | -$8.9M |
| Litigation settlements | $7.3M+1012.5% | -$800K-107.5% | $10.6M+136.2% | -$29.3M | $0-100.0% | $1.2M+500.0% | $200K-99.6% | $46.0M |
| Loss on debt extinguishment | $1.3M-74.5% | $5.1M-67.1% | $15.5M+4.0% | $14.9M+63.7% | $9.1M | $0-100.0% | $11.7M | $0 |
| Other income, net | -$8.7M+56.5% | -$20.0M-166.7% | -$7.5M+60.5% | -$19.0M-22.6% | -$15.5M-811.8% | -$1.7M-21.4% | -$1.4M+62.2% | -$3.7M |
| Total operating expenses | $2.92B+5.6% | $2.77B+14.5% | $2.42B+10.1% | $2.19B+14.1% | $1.92B+14.7% | $1.68B+5.1% | $1.60B-5.8% | $1.69B |
| Operating income | $389.5M+11.7% | $348.8M+6.3% | $328.0M-5.0% | $345.2M+14.2% | $302.2M+65.1% | $183.0M-22.4% | $235.9M+203.2% | $77.8M |
| Interest expense, net | -$272.6M-35.2% | -$201.7M-4.5% | -$193.0M+17.8% | -$234.9M-6.3% | -$221.0M-9.5% | -$201.8M-12.8% | -$178.9M-21.7% | -$147.0M |
| Income before income taxes | $116.9M-20.5% | $147.1M+9.0% | $135.0M+22.4% | $110.3M+35.8% | $81.2M+531.9% | -$18.8M-134.4% | $54.6M+178.9% | -$69.2M |
| Income tax (expense) benefit | -$18.0M+86.6% | -$134.6M-44966.7% | $300K+101.3% | -$23.3M-121.9% | -$10.5M-152.2% | $20.1M+111.6% | $9.5M-64.0% | $26.4M |
| Net income | $98.9M+691.2% | $12.5M-90.8% | $135.3M+55.5% | $87.0M+23.1% | $70.7M+5338.5% | $1.3M-97.1% | $45.1M+147.2% | -$95.6M |
| Less: Net income attributable to non-controlling interests | -$176.8M+2.1% | -$180.6M-22.7% | -$147.2M-4.0% | -$141.6M+0.0% | -$141.6M-20.6% | -$117.4M+2.1% | -$119.9M-8.9% | -$110.1M |
| Net loss attributable to Surgery Partners, Inc. | -$77.9M+53.7% | -$168.1M-1312.6% | -$11.9M+78.2% | -$54.6M+23.0% | -$70.9M+38.9% | -$116.1M-55.2% | -$74.8M+63.6% | -$205.7M |
| Basic (in USD per share) | -$610000.00+54.1% | -$1330000.00-1377.8% | -$90000.00+84.7% | -$590000.00+47.3% | -$1120000.00+64.9% | -$3190000.00-39.3% | -$2290000.00 | — |
| Diluted (in USD per share) | -$610000.00+54.1% | -$1330000.00-1377.8% | -$90000.00+84.7% | -$590000.00+47.3% | -$1120000.00+64.9% | -$3190000.00-39.3% | -$2290000.00 | — |
| Basic (shares) | $127.21B+0.9% | $126.12B+0.4% | $125.61B+36.6% | $91.95B+27.0% | $72.43B+48.5% | $48.78B+1.0% | $48.28B | — |
| Diluted (shares) | $127.21B+0.9% | $126.12B+0.4% | $125.61B+36.6% | $91.95B+27.0% | $72.43B+48.5% | $48.78B+1.0% | $48.28B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.